AstraZeneca

ASTRAZENECA NEWSROOM (2 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

AstraZeneca’s Imfinzi Regimen Approved in the European Union for Early-Stage Gastric and Gastroesophageal Junction Cancers

PRESS RELEASE -- 16, March 2026

(IN BRIEF) AstraZeneca has received approval from the European Commission for the use of Imfinzi (durvalumab) in combination with FLOT chemotherapy as a perioperative treatment for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers. The approval … Read the full press release →

AstraZeneca Unveils Major Long-Term Investment to Strengthen China as a Global Hub for Life Sciences Innovation

PRESS RELEASE -- 29, January 2026

(IN BRIEF) AstraZeneca has announced a $15 billion investment in China through 2030 to expand research, development and manufacturing capabilities, supporting its long-term growth strategy and global pipeline in advanced treatment modalities such as cell therapy and radioconjugates. The investment … Read the full press release →